SCHEMBL4926844

SCHEMBL4926844

Oc1cccc2c1CC(c1ccccc1)NN2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
PRCP P42785 1/20 0.34
NPC1 O15118 1/20 0.34
MAPT P10636 2/20 0.34
KDM4E B2RXH2 1/20 0.34
GAA P10253 1/20 0.34
BRD4 O60885 1/20 0.33
CA1 P00915 2/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
HPGD P15428 1/20 0.33
ALOX12 P18054 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5179397 0.66 SMN1; SMN2 (0.43) MEN1KMT2APRCPMAPTGAA
SCHEMBL7809939 0.65 DRD2 (0.37) MEN1KMT2AMAPTGAACA1
Hydrochloric Acid SCHEMBL8743281 0.65 PRCP (0.40) MEN1KMT2APRCPNPC1MAPT
SCHEMBL14247747 0.64 BCL2L1 (0.38) MEN1KMT2ANPC1MAPTKDM4E
SCHEMBL5771626 0.63 CREBBP (0.44) MEN1KMT2ABRD4RAB9ADRD2
SCHEMBL15506305 0.60 MEN1 (0.46) MEN1KMT2APRCPNPC1MAPT
SCHEMBL20777507 0.59 BCL2L1 (0.45) CA1ALDH1A1HPGDDRD2DRD3
SCHEMBL29779937 0.59 PRCP (0.55) MEN1KMT2APRCPNPC1MAPT
SCHEMBL4978935 0.59 PRCP (0.55) MEN1KMT2APRCPNPC1MAPT
SCHEMBL20554529 0.58 PTGS1 (0.56) MEN1KMT2AMAPTKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039468-A1 Novel 3-Phenyltetrahydrocinnolin-5-Ol Derivative and Medicinal Use Thereof NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2008-02-14 US claimed
EP-1757592-A1 NOVEL 3-PHENYLTETRAHYDROCINNOLIN-5-OL DERIVATIVE AND MEDICINAL USE THEREOF Nippon Kayaku Kabushiki Kaisha (JP) 2007-02-28 EP claimed
US-20080039468-A1 Novel 3-Phenyltetrahydrocinnolin-5-Ol Derivative and Medicinal Use Thereof NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2008-02-14 US disclosed
US-20080039468-A1 Novel 3-Phenyltetrahydrocinnolin-5-Ol Derivative and Medicinal Use Thereof NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2008-02-14 US disclosed
US-20080039468-A1 Novel 3-Phenyltetrahydrocinnolin-5-Ol Derivative and Medicinal Use Thereof NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2008-02-14 US disclosed
CN-1964953-A Novel 3-phenyltetrahydrocinnolin-5-ol derivative and medical use thereof NIPPON KAYAKU KK (JP) 2007-05-16 CN disclosed
CN-1964953-A Novel 3-phenyltetrahydrocinnolin-5-ol derivative and medical use thereof NIPPON KAYAKU KK (JP) 2007-05-16 CN disclosed
EP-1757592-A8 NOVEL 3-PHENYLTETRAHYDROCINNOLIN-5-OL DERIVATIVE AND MEDICINAL USE THEREOF Nippon Kayaku Kabushiki Kaisha (JP) 2007-05-09 EP disclosed
EP-1757592-A1 NOVEL 3-PHENYLTETRAHYDROCINNOLIN-5-OL DERIVATIVE AND MEDICINAL USE THEREOF Nippon Kayaku Kabushiki Kaisha (JP) 2007-02-28 EP disclosed
EP-1757592-A1 NOVEL 3-PHENYLTETRAHYDROCINNOLIN-5-OL DERIVATIVE AND MEDICINAL USE THEREOF Nippon Kayaku Kabushiki Kaisha (JP) 2007-02-28 EP disclosed
WO-2005121105-A1 NOVEL 3-PHENYLTETRAHYDROCINNOLIN-5-OL DERIVATIVE AND MEDICINAL USE THEREOF NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2005-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039468-A1 Novel 3-Phenyltetrahydrocinnolin-5-Ol Derivative and Medicinal Use Thereof TPX2, HCCS, YWHAZ SLC6A2 4826/4885SLC6A4 4710/4885SLC6A3 4364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.